1-20 of 20
Authors: Kieran F. Docherty
Sort by
Journal Article
ACCEPTED MANUSCRIPT
The intersection of obesity and acute heart failure: Cardiac structure and function and congestion across BMI categories
Get access
Sofie Bøgh-Sørensen and others
European Heart Journal. Acute Cardiovascular Care, zuaf067, https://doi.org/10.1093/ehjacc/zuaf067
Published: 28 April 2025
Journal Article
Advocating for better care of patients with heart failure
Get access
Kieran F Docherty and others
European Heart Journal, ehaf224, https://doi.org/10.1093/eurheartj/ehaf224
Published: 24 April 2025
Journal Article
Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient data analysis
Matthew Ryan and others
European Heart Journal, ehaf080, https://doi.org/10.1093/eurheartj/ehaf080
Published: 06 March 2025
Journal Article
Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease
John W Ostrominski and others
European Heart Journal, Volume 46, Issue 14, 7 April 2025, Pages 1321–1331, https://doi.org/10.1093/eurheartj/ehae780
Published: 21 November 2024
Journal Article
Subcutaneous furosemide in heart failure: a systematic review
Joanna Osmanska and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 1, January 2025, Pages 94–104, https://doi.org/10.1093/ehjcvp/pvae083
Published: 08 November 2024
Journal Article
EDITOR'S CHOICE
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies
Joanna Osmanska and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 1, January 2024, Pages 35–44, https://doi.org/10.1093/ehjcvp/pvad073
Published: 06 October 2023
Journal Article
Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER
Jawad H Butt and others
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2170–2183, https://doi.org/10.1093/eurheartj/ehad276
Published: 23 May 2023
Journal Article
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
Su Ern Yeoh and others
European Heart Journal, Volume 44, Issue 31, 14 August 2023, Pages 2966–2977, https://doi.org/10.1093/eurheartj/ehad341
Published: 21 May 2023
Journal Article
Serum bicarbonate and congestion: a potential biomarker for identifying and guiding management in diuretic resistance?
Ross T Campbell and Kieran F Docherty
European Heart Journal, Volume 44, Issue 22, 7 June 2023, Pages 2006–2008, https://doi.org/10.1093/eurheartj/ehad209
Published: 10 May 2023
Journal Article
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?
Kieran F Docherty and others
European Heart Journal Supplements, Volume 24, Issue Supplement_L, December 2022, Pages L10–L19, https://doi.org/10.1093/eurheartjsupp/suac113
Published: 19 December 2022
Journal Article
A welcome ‘failure’ of gliflozins: blood pressure reduction in heart failure
Kieran F Docherty and Pardeep S Jhund
European Heart Journal, Volume 44, Issue 5, 1 February 2023, Pages 408–410, https://doi.org/10.1093/eurheartj/ehac712
Published: 14 December 2022
Journal Article
Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis
Guoli Sun and others
in
Rheumatology
Rheumatology, Volume 61, Issue 11, November 2022, Pages 4374–4383, https://doi.org/10.1093/rheumatology/keac072
Published: 08 February 2022
Journal Article
Sodium-glucose cotransporter 2 inhibitors: the first universal treatment for heart failure?
Kirsty McDowell and Kieran F Docherty
European Heart Journal - Quality of Care and Clinical Outcomes, Volume 8, Issue 4, July 2022, Pages 371–373, https://doi.org/10.1093/ehjqcco/qcab088
Published: 22 November 2021
Journal Article
EDITOR'S CHOICE
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF
James P Curtain and others
European Heart Journal, Volume 42, Issue 36, 21 September 2021, Pages 3727–3738, https://doi.org/10.1093/eurheartj/ehab560
Published: 27 August 2021
Journal Article
Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis
Matthew M Y Lee and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 2, March 2022, Pages 165–178, https://doi.org/10.1093/ehjcvp/pvaa138
Published: 31 December 2020
Journal Article
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)
Matteo Serenelli and others
European Heart Journal, Volume 41, Issue 36, 21 September 2020, Pages 3402–3418, https://doi.org/10.1093/eurheartj/ehaa496
Published: 21 August 2020
Journal Article
The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
John J V McMurray and others
European Heart Journal, Volume 42, Issue 13, 1 April 2021, Pages 1199–1202, https://doi.org/10.1093/eurheartj/ehz916
Published: 07 May 2020
Journal Article
EDITOR'S CHOICE
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Kieran F Docherty and others
European Heart Journal, Volume 41, Issue 25, 1 July 2020, Pages 2379–2392, https://doi.org/10.1093/eurheartj/ehaa183
Published: 28 March 2020
Journal Article
PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction
Get access
Kieran F Docherty and John J V McMurray
Cardiovascular Research, Volume 115, Issue 13, 1 November 2019, Pages e136–e139, https://doi.org/10.1093/cvr/cvz223
Published: 08 September 2019
Journal Article
How robust are clinical trials in heart failure?
Get access
Kieran F. Docherty and others
European Heart Journal, Volume 38, Issue 5, 1 February 2017, Pages 338–345, https://doi.org/10.1093/eurheartj/ehw427
Published: 14 October 2016